Adaptin Bio, Inc. Research and Development Expense
Adaptin Bio, Inc. (APTN) reported Research and Development Expense of $138.17 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-28
- Adaptin Bio, Inc. research and development expense for the quarter ending 2026-06-30 was $138.17K, a 59.40% decline year-over-year.
- Adaptin Bio, Inc. research and development expense for the quarter ending 2026-03-31 was $165.58K, a 166.49% increase year-over-year.
- Adaptin Bio, Inc. research and development expense for the quarter ending 2025-12-31 was $593.03K, a 129.81% increase year-over-year.
- Adaptin Bio, Inc. research and development expense for the quarter ending 2025-09-30 was $778.66K, a 14.08% increase year-over-year.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $138.17K S-1 · filed 2026-08-28 | $303.74K S-1 · filed 2026-08-28 | $896.78K derived: sum of 3 quarters · filed 2026-08-28 | $1.68M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $165.58K POS AM · filed 2026-07-21 | $758.61K derived: sum of 2 quarters · filed 2026-08-28 | $1.54M derived: sum of 3 quarters · filed 2026-08-28 | $1.88M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $593.03K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $1.37M derived: sum of 2 quarters · filed 2026-08-28 | $1.71M derived: sum of 3 quarters · filed 2026-08-28 | $1.77M S-1 · filed 2026-08-28 |
| 2025-09-30 | $778.66K 10-Q · filed 2025-11-14 | $1.12M derived: sum of 2 quarters · filed 2026-08-28 | $1.18M 10-Q · filed 2025-11-14 | $1.44M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | $340.33K S-1 · filed 2026-08-28 | $402.47K S-1 · filed 2026-08-28 | $660.52K derived: sum of 3 quarters · filed 2026-08-28 | $1.34M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | $62.13K POS AM · filed 2026-07-21 | $320.19K derived: sum of 2 quarters · filed 2026-08-28 | $1.00M derived: sum of 3 quarters · filed 2026-08-28 | $1.69M derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | $258.06K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $940.60K derived: sum of 2 quarters · filed 2026-08-28 | $1.63M derived: sum of 3 quarters · filed 2026-08-28 | $1.82M S-1 · filed 2026-08-28 |
| 2024-09-30 | $682.55K 10-Q · filed 2025-11-14 | $1.37M derived: sum of 2 quarters · filed 2025-11-14 | $1.57M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $685.03K 10-Q · filed 2025-08-14 | $883.99K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $198.96K 10-Q · filed 2025-05-15 |